Atoxigen
Provider of early-stage and regulated R&D and testing services focused on dermatological models and in vitro toxicology. Services include development and use of reconstructed 3D tissue and ex vivo skin models, in vitro ADMET and endocrine disruptor testing, microbiome analyses, GLP study support, and product sustainability assessment. The organisation emphasises alternatives to animal testing and compliance with relevant European regulatory criteria.
Industries
Nr. of Employees
small (1-50)
Products
Synthetic skin models
Reconstructed synthetic skin constructs developed for testing and to reduce reliance on animal testing.
Synthetic skin models
Reconstructed synthetic skin constructs developed for testing and to reduce reliance on animal testing.
Services
Tailored R&D services to develop and adapt in vitro and ex vivo models according to project requirements.
Provision of routine and specialised in vitro assays for safety and efficacy testing.
Testing and interpretation services to identify endocrine-disrupting properties and support regulatory compliance.
Analytical assays and research services addressing microbiome-related questions in product development.
Testing using human or relevant ex vivo skin explants to evaluate product effects and disease models.
Advisory support related to evolving European regulatory requirements for cosmetics and medical devices.
Tailored R&D services to develop and adapt in vitro and ex vivo models according to project requirements.
Provision of routine and specialised in vitro assays for safety and efficacy testing.
Testing and interpretation services to identify endocrine-disrupting properties and support regulatory compliance.
Analytical assays and research services addressing microbiome-related questions in product development.
Testing using human or relevant ex vivo skin explants to evaluate product effects and disease models.
Advisory support related to evolving European regulatory requirements for cosmetics and medical devices.
Expertise Areas
- In vitro ADMET testing
- 3D tissue model development
- Dermatological and ex vivo skin testing
- Endocrine disruptor assessment
Key Technologies
- In vitro ADMET assays
- Reconstructed 3D tissue/skin models
- Ex vivo skin explant testing
- Microbiome analytical assays
News & Updates
Exhibited at In-Cosmetics Global trade show (Amsterdam, 2018).
Discussion and references regarding state commitments and national measures addressing endocrine disruptors in consumer products.
Award for use of alternative animal testing methods and work on synthetic skin models; prize €3,000.
Exhibited at In-Cosmetics Global trade show (Amsterdam, 2018).
Discussion and references regarding state commitments and national measures addressing endocrine disruptors in consumer products.
Award for use of alternative animal testing methods and work on synthetic skin models; prize €3,000.